Immunohistochemical and multiplexed analyses in OSCC demonstrated that PD-1 is commonly expressed on tumor-infiltrating lymphocytes and that PD-L1 is frequently, but variably, expressed on OSCC tumor cells and tumor stromal cells. The gene discussed is CD274; the disease is neoplasm.